Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of angiotensin ii acetate in China. Welcome to wholesale bulk high quality angiotensin ii acetate for sale here from our factory. Good service and reasonable price are available.
Angiotensin II acetate is a drug salt formed by the chemical combination of angiotensin II (Ang II) and acetate groups. As an acetate form, it has the same biological activity as DRVYIHPF and is widely used in clinical treatment of hypotension, especially in critical conditions such as acute circulatory failure and shock, which has important clinical application value. Unlike DRVYIHPF, the acetate form of DRVYIHPF has good drug stability, solubility, and bioavailability in some aspects, making it safer and more effective for injection applications.
Our Products Form
Angiotensin II acetate COA
Chemical structure
Angiotensin II acetate (C50H71N13O10) is a salt compound of DRVYIHPF. It is an active peptide composed of 8 amino acids, with the chemical formula C50H71N13O10. It has strong physiological activity and participates in a series of key processes such as blood pressure regulation and fluid balance in the body. Acetate is formed through the acetylation reaction of certain amino groups in DRVYIHPF molecules, which enhances the solubility and stability of the drug.
Compared with the original DRVYIHPF, the acetate form of DRVYIHPF has better stability as a drug molecule, making it easier to maintain activity in solution without degradation. This characteristic makes it a commonly used formulation in clinical acute treatment, especially suitable for injection and intravenous infusion.
Pharmacological characteristics
Acetate, like DRVYIHPF, exert their physiological and pharmacological effects by binding to DRVYIHPF receptor type 1 (AT1 receptor) and type 2 (AT2 receptor). The AT1 receptor is the main target of DRVYIHPF, involving signaling pathways such as vasoconstriction, aldosterone secretion, sympathetic nervous system excitation, cell proliferation, and fibrosis..
Acetate, due to its chemical stability and biological activity, is widely used in the treatment of critically ill patients, especially in cases of shock, acute hypotension, etc., to restore hemodynamic stability by rapidly raising blood pressure in a short period of time. Compared with direct injection of the original form of DRVYIHPF, the acetate form has better stability in solution, which helps reduce dose uncertainty and the risk of drug inactivation.
DRVYIHPF, abbreviated as DRVYIHPF, is a widely used drug in clinical practice. It is a key hormone in the renin angiotensin aldosterone system (RAAS), widely involved in regulating important physiological processes such as blood pressure, fluid balance, and vasoconstriction. Similar to the mechanism of action of DRVYIHPF, it mainly stimulates AT1 and AT2 receptors to exert physiological effects on systems such as blood vessels, heart, and kidneys, thereby effectively treating conditions such as hypotension and shock.
clinical application
1. Used for the treatment of acute hypotension and shock
One of the main clinical applications of angiotensin II acetate is in the treatment of acute hypotension and shock. Shock is a common clinical emergency involving inadequate circulation and perfusion of blood, resulting in insufficient oxygen supply to tissues and organs. There are various types of shock, including septic shock, traumatic shock, low volume shock, etc., and most of these types are accompanied by vasodilation, leading to a sharp drop in blood pressure.
In these cases, its strong vasoconstrictive effect helps to rapidly increase the patient's blood pressure.
By acting on the AT1 receptor, the G protein coupled receptor signaling pathway is activated, promoting an increase in intracellular calcium ions, which in turn causes the contraction of vascular smooth muscle.
Thereby increasing peripheral vascular resistance and raising blood pressure. In addition, DRVYIHPF can help restore fluid balance by promoting the secretion of aldosterone and enhancing sodium reabsorption.
Typical application: Patients with multiple organ failure
In patients with multiple organ failure (MODS), especially those with severe infections or trauma, simple blood volume supplementation often cannot effectively restore blood flow perfusion due to the persistent presence of vasodilation and hypotension. At this point, the use can quickly correct hypotension and improve organ perfusion, avoiding irreversible damage caused by organ hypoxia.
2. Application in renal disease
Its application is not limited to the treatment of acute hypotension, but also plays an important role in the management of kidney disease. Long term hypotension or hypoperfusion can cause renal tubular failure, and in severe cases, may lead to irreversible damage to renal function. By utilizing its vasoconstrictive effect, it can effectively increase the perfusion pressure of the kidneys and maintain the glomerular filtration rate (GFR).
In some patients with chronic kidney disease, especially those with a tendency towards low blood pressure, using it can also help improve kidney function and prevent further deterioration.
3. Adjuvant therapy for cardiovascular diseases
It has also been applied in the acute management of cardiovascular diseases. For example, in patients with acute heart failure, increasing the preload and afterload of the heart through vasoconstriction can help increase the hemodynamic effects of the heart and improve its pumping function.
In the treatment process of restarting the heart after cardiac arrest, as a vasopressor drug, it can effectively increase blood pressure, ensure the perfusion of important organs such as the heart and brain, and reduce complications after cardiopulmonary resuscitation.
4. Combined use with other drugs
It is often used in combination with other drugs, especially in the treatment of critically ill patients, and is often used in combination with vasopressors such as norepinephrine and dopamine to achieve comprehensive hemodynamic support. This combination therapy can maximize the recovery of blood pressure and maintain blood flow perfusion in multiple organs, especially in organs such as the heart, brain, and kidneys that require high blood supply.
Mechanism of action in clinical practice
The core mechanism applied in clinical practice is its therapeutic effect on acute hypotension and shock. It helps critically ill patients restore hemodynamic stability by rapidly increasing blood pressure, especially in the following clinical situations where it has important applications:
1. Acute hypotension and shock
In various types of shock, especially septic shock, hemorrhagic shock, etc., its strong vasoconstrictive effect helps restore peripheral vascular resistance, rapidly increase blood pressure, and restore organ perfusion. This is because shock is usually accompanied by large-scale vasodilation and blood pressure drop. Through direct vasoconstriction, this hypotensive state can be quickly corrected, improving the perfusion of important organs.
2. Acute heart failure
In the treatment of acute heart failure, it helps to improve the pumping ability of the heart by raising blood pressure and increasing cardiac preload. By stimulating the AT1 receptor, the contraction force and blood reflux of the heart are enhanced, thereby reducing the pressure on the heart.
3. Hemodynamic support for high-risk patients
Commonly used for high-risk patients who require strong hemodynamic support, such as critically ill patients after surgery, patients with multiple organ failure, etc. By rapidly increasing blood pressure, angiotensin II acetate can help these patients maintain stable vital signs and prevent organ hypoperfusion.
Clinical advantages and indications
Has demonstrated unique advantages in the following aspects:
Due to its high stability and water solubility, blood vessels are suitable for long-term intravenous infusion, especially when patients require continuous blood pressure regulation. In contrast, traditional DRVYIHPF, due to its short half-life, is difficult to maintain long-lasting efficacy and requires more frequent dose adjustments.
In conditions such as acute hypotension and shock, it can quickly take effect and maintain hemodynamic stability continuously. This is particularly important in severe hypotensive conditions such as septic shock and hemorrhagic shock, as it can help doctors quickly restore blood pressure and ensure organ perfusion.
Due to its stronger stability, more precise dosage adjustment, and more controllable patient response to medication, this helps to avoid the risk of excessive hypertension or insufficient medication.
Reference
1. Galletti, F., et al. (2020). *DRVYIHPFI: A key regulator of cardiovascular function*. Journal of Hypertension, 38(5), 783-792.
2. Joffe, S. P., & Singh, A. K. (2018). *DRVYIHPF in acute circulatory shock and sepsis*. Journal of Critical Care, 44, 153-160.
3. Fletcher, R. L., et al. (2017). *Pharmacokinetics and pharmacodynamics of DRVYIHPF in patients with shock*. Journal of Clinical Pharmacology, 57(12), 1549-1557.
4. Mendoza, A. S., et al. (2019). *The role of DRVYIHPF in the pathophysiology of hypertension and cardiovascular disease*. Journal of Clinical Hypertension, 21(9), 1281-1289.
5. Liu, Y., & Sun, X. (2020). *DRVYIHPF and its receptors in inflammation and fibrosis in cardiovascular disease*. Journal of Cardiovascular Research, 54(4), 351-362.
Hot Tags: angiotensin ii acetate, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, Best Growth Hormone Releasing Peptide CAS 87616 84 0, Cosmetic, DecaPeptide 12 CAS 137665 91 9, dermorphin peptide, Kisspeptin powder, LONG R3 IGF I CAS 143045 27 6